DSM-Firmenich AG/€DSFIR
06:30
10:10
13:45
17:25
21:00
1D1W1MYTD1Y5YMAX
About DSM-Firmenich AG
DSM-Firmenich AG, established in May 2023 through the merger of Dutch company DSM N.V. and Swiss company Firmenich SA, operates in the nutrition, health, and beauty industries. The company is organized into four segments: Perfumery & Beauty, offering fragrance solutions; Taste, Texture & Health, providing food and beverage ingredients; Health, Nutrition & Care, delivering dietary supplements and medical nutrition products; and Animal Nutrition & Health, supplying animal feed ingredients. Headquartered in Kaiseraugst, Switzerland, and Maastricht, Netherlands, DSM-Firmenich has operations in nearly 60 countries and employs approximately 30,000 people. The merger combines DSM's expertise in health and nutrition with Firmenich's capabilities in perfumery and taste, positioning the company to offer integrated solutions across its sectors. (,)
Ticker
€DSFIR
Sector
Primary listing
AEX
Employees
26,873
Headquarters
Kaiseraugst, Switzerland
Website
DSM-Firmenich AG Metrics
BasicAdvanced
€14B
-
-€4.27
0.89
€2.50
1.84%
Price and volume
Market cap
€14B
Beta
0.89
52-week high
€99.92
52-week low
€55.40
Average daily volume
3K
Dividend rate
€2.50
Financial strength
Current ratio
1.59
Quick ratio
0.71
Long term debt to equity
19.633
Total debt to equity
28.644
Interest coverage (TTM)
4.08%
Profitability
EBITDA (TTM)
1,622
Gross margin (TTM)
39.07%
Net profit margin (TTM)
-11.97%
Operating margin (TTM)
7.87%
Effective tax rate (TTM)
25.65%
Revenue per employee (TTM)
€340,000
Management effectiveness
Return on assets (TTM)
1.25%
Return on equity (TTM)
1.66%
Valuation
Price to revenue (TTM)
1.66
Price to book
0.78
Price to tangible book (TTM)
5.15
Price to free cash flow (TTM)
22.023
Free cash flow yield (TTM)
4.54%
Free cash flow per share (TTM)
2.626
Dividend yield (TTM)
4.32%
Forward dividend yield
1.84%
Growth
Revenue change (TTM)
-29.42%
Earnings per share change (TTM)
-608.94%
3-year revenue growth (CAGR)
2.50%
10-year revenue growth (CAGR)
1.58%
3-year earnings per share growth (CAGR)
-24.12%
10-year earnings per share growth (CAGR)
25.31%
3-year dividend per share growth (CAGR)
-0.40%
10-year dividend per share growth (CAGR)
4.24%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.
Capital at risk
Upcoming events
FAQs
What’s the current market cap for DSM-Firmenich AG stock?
DSM-Firmenich AG (DSFIR) has a market cap of €14B as of March 10, 2026.
What is the P/E ratio for DSM-Firmenich AG stock?
The price to earnings (P/E) ratio for DSM-Firmenich AG (DSFIR) stock is 0 as of March 10, 2026.
Does DSM-Firmenich AG stock pay dividends?
Yes, the DSM-Firmenich AG (DSFIR) stock pays dividends to shareholders. As of March 10, 2026, the dividend rate is €2.5 and the yield is 1.84%. DSM-Firmenich AG has a payout ratio of 0% on a trailing twelve-month basis.
When is the next DSM-Firmenich AG dividend payment date?
The next DSM-Firmenich AG (DSFIR) dividend payment is scheduled for May 19, 2026.
What is the beta indicator for DSM-Firmenich AG?
DSM-Firmenich AG (DSFIR) has a beta rating of 0.89. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.